TBC1D4 Antikörper (PE)
Kurzübersicht für TBC1D4 Antikörper (PE) (ABIN2179538)
Target
Alle TBC1D4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human TBC1D4
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
FCM: (1:20-100)
Optimal working dilution should be determined by the investigator. -
Kommentare
-
Exitation/Emission: 480,565nm/578nm
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 100 μg/mL BSA, 50 % glycerol and 0.09 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at 4 °C for 12 months.
-
-
- TBC1D4 (TBC1 Domain Family, Member 4 (TBC1D4))
-
Andere Bezeichnung
- Tbc1d4
-
Hintergrund
-
May act as a GTPase-activating protein for RAB2A, RAB8A, RAB10 and RAB14. Isoform 2 promotes insulin-induced glucose transporter SLC2A4/GLUT4 translocation at the plasma membrane, thus increasing glucose uptake.
Synonyms: Acrg embryonic lethality mouse minimal region ortholog, Acrg embryonic lethality minimal region ortholog, Acrg embryonic lethality mouse minimal region ortholog, Akt substrate of 160 kDa, AS 160, AS160, TBC Tre 2 BUB2 CDC16 domain containing protein, TBC Tre 2 BUB2 CDC16 domain containing protein, TBC1 D4, TBC1 domain family member 4, Tbc1d4, TBCD4_HUMAN. -
Gen-ID
- 9882
Target
-